For research use only. Not for therapeutic Use.
Caffeine Citrate is a compound formed by combining caffeine with citric acid, resulting in a more water-soluble and bioavailable form of caffeine. It is primarily used as a central nervous system stimulant and respiratory stimulant, particularly in neonatal care to treat apnea of prematurity—a condition where premature infants stop breathing for short periods. Caffeine Citrate is preferred in this context due to its rapid onset of action and predictable pharmacokinetics. Additionally, it is used in over-the-counter medications and dietary supplements to improve alertness and reduce fatigue.
Catalog Number | R059366 |
CAS Number | 69-22-7 |
Synonyms | 2-Hydroxy-1,2,3-propanetricarboxylic Acid 3,7-Dihydro-1,3,7-trimethyl-?1H-purine-2,6-dione; Citrated Caffeine; |
Molecular Formula | C14H18N4O9 |
Purity | ≥95% |
Storage | RT |
IUPAC Name | 2-hydroxypropane-1,2,3-tricarboxylic acid;1,3,7-trimethylpurine-2,6-dione |
InChI | InChI=1S/C8H10N4O2.C6H8O7/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2;7-3(8)1-6(13,5(11)12)2-4(9)10/h4H,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) |
InChIKey | RCQXSQPPHJPGOF-UHFFFAOYSA-N |
SMILES | CN1C=NC2=C1C(=O)N(C(=O)N2C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |